The Rheumatology Network COVID-19 clinical focus page provides information on the latest COVID-19 news, study and clinical trial findings, and clinical guideline updates for the treatment of COVID-19. We feature expert interviews with leading physicians and investigators, articles, videos, podcasts, and breaking FDA approvals for COVID-19 drugs.

Targeted Biologics Did Not Affect Humoral Immunity to First Dose of COVID-19 Vaccine

July 29, 2021

Common immunosuppressant therapies for patients with rheumatic disease, such as methotrexate and targeted biologics, increase risk of serious infection, especially with respiratory pathogens. A recent study investigates the connection between these drugs and functional humoral immunity to the first dose of the COVID-19 vaccine BNT162b2 (Pfizer-BioNTech).

Concierge Medicine: A Rewarding Option for Rheumatologists

July 08, 2021

Irene Kazmers, MD, discusses the heavy administrative burden placed on all practicing physicians in the last decade and why she chose to begin concierge, or membership medicine, a practice model that has "proven to be a tremendous fit for my career at this point in time and made it possible for me to continue as a practicing rheumatologist."

Autoimmune Inflammatory Rheumatic Diseases, High-Dose Corticosteroids Linked to Poor COVID-19 Outcomes

July 07, 2021

Patients with autoimmune inflammatory rheumatic diseases had an increased risk of testing positive for SARS-CoV-2 and worse clinical outcomes of COVID-19, including death, although disease-modifying antirheumatic drugs (DMARDs) did not increase the risk of these outcomes.

Q&A: Rheumatoid Arthritis Linked to More Severe COVID-19 Outcomes

May 11, 2021

Bryant England, MD, PhD, discusses his study, "Risk of COVID‐19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At‐Risk Individuals." Investigators found that patients with rheumatoid arthritis (RA) are not only at a higher risk for contracting COVID-19, they are more likely to have severe outcomes, such as hospitalization and death, when compared with the general population.

Patients With Rheumatic Diseases Are More Likely to Avoid Healthcare During COVID-19 Pandemic

May 04, 2021

Poorer results were associated with lower socioeconomic status (SES) and not being able to access telehealth, which emphasizes the need for access to healthcare and attention to vulnerable populations, such as those with rheumatic diseases, during the pandemic.